Why FUGO’s integrated printing cycle could shift dental manufacturing economics
FUGO Precision 3D is debuting its centrifugal 3D printing tech at LMT LAB DAY 2026. Find out how this could transform dental manufacturing workflows.
Medical Devices & Diagnostics
Medical Devices & Diagnostics
Trace Biosciences’ LGW16-03 IND approval opens new chapter in nerve-targeted surgical imaging
Trace Biosciences receives IND approval for LGW16-03. Find out what this means for nerve imaging and the future of surgical precision.
Medical Devices & Diagnostics
Cynosure Lutronic sets stage for global Mosaic 3D rollout with IMCAS 2026 momentum
Find out how Cynosure Lutronic’s Mosaic 3D laser device could redefine non-ablative resurfacing after CE mark approval under EU MDR.
Medical Devices & Diagnostics
Why UVDI’s new V-MIX air disinfection system could reshape HVAC pathogen control
Find out how UVDI’s V-MIX UV-C disinfection system is pushing upper-room air safety beyond hospitals into schools, offices, and airports.
Medical Devices & Diagnostics
What KORU Medical’s RYSTIGGO delivery clearance means for subcutaneous infusion models
KORU Medical’s FreedomEDGE gets FDA clearance for RYSTIGGO delivery in clinics. Find out how this expands access to gMG therapy and reshapes infusion workflows.
Medical Devices & Diagnostics
What Hera BioLabs’ absorption into Demeetra reveals about IP bottlenecks in gene editing R&D
Demeetra’s acquisition of Hera BioLabs consolidates Super piggyBac IP. Find out how this could reshape gene therapy tools and licensing frameworks.
Medical Devices & Diagnostics
Could Fujirebio’s pTau 217 CSF assay become a new standard in Alzheimer’s research?
Find out how Fujirebio’s new Lumipulse pTau 217 CSF assay could shape the future of Alzheimer’s biomarker research and platform-based diagnostics.
Medical Devices & Diagnostics
What the USDTL–CourtFact deal reveals about tech’s role in court-managed care
Find out how USDTL’s integration with CourtFact could reshape digital drug testing workflows for justice-involved programs.
Medical Devices & Diagnostics
Abanza gains 510(k) for QuadLock ACL system: But is this a clinical leap or an engineering refinement?
Abanza Inc. has received U.S. Food and Drug Administration (FDA) 510(k) clearance for QuadLock, its novel knotless fixation system for anterior cruciate ligament (ACL) reconstruction. The system, which features a bidirectional tension-adjustable design, reportedly offers over a 500% reduction in cyclic displacement compared to conventional fixation methods such as cortical buttons and interference screws, targeting
Medical Devices & Diagnostics
Merz Therapeutics files XEOMIN pediatric spasticity indication with EMA following Phase 3 success
Merz Therapeutics files EMA application to expand XEOMIN for pediatric spasticity. Find out how this could shift the treatment landscape for cerebral palsy.